Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting

Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting

[at noodls] – Safe Harbor Statement These presentations contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. You are cautioned not to rely on these forward-looking … more

View todays social media effects on JNJ

View the latest stocks trending across Twitter. Click to view dashboard

Share this post